Tumour-stromal interactions in acid-mediated invasion: a mathematical model.
It is well established that the tumour microenvironment can both promote and suppress tumour growth and invasion, however, most mathematical models of invasion view the normal tissue as inhibiting tumour progression via immune modulation or spatial constraint. In particular, the production of acid by tumour cells and the subsequent creation of a low extracellular pH environment has been explored in several 'acid-mediated tumour invasion' models where the acidic environment facilitates normal cell death and permits tumour invasion. In this paper, we extend the acid-invasion model developed by Gatenby and Gawlinski (1996) to include both the competitive and cooperative interactions between tumour and normal cells, by incorporating the influence of extracellular matrix and protease production at the tumour-stroma interface. Our model predicts an optimal level of tumour acidity which produces both cell death and matrix degradation. Additionally, very aggressive tumours prevent protease production and matrix degradation by excessive normal cell destruction, leading to an acellular (but matrix filled) gap between the tumour and normal tissue, a feature seen in encapsulated tumours. These results suggest, counterintuitively, that increasing tumour acidity may, in some cases, prevent tumour invasion.
Martin
Natasha K
NK
Centre for Mathematical Biology, Mathematical Institute, Oxford University, 24-29 St Giles', Oxford OX1 3LB, UK. natasha.martin@bristol.ac.uk
Gaffney
Eamonn A
EA
Gatenby
Robert A
RA
Maini
Philip K
PK
D000465:Algorithms; D000818:Animals; D016923:Cell Death / Q000502:physiology; D003198:Computer Simulation; D003238:Connective Tissue / Q000378:metabolism*; D005109:Extracellular Matrix / Q000378:metabolism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D045726:Metalloproteases / Q000378:metabolism; D008954:Models, Biological; D009361:Neoplasm Invasiveness; D009369:Neoplasms / Q000378:metabolism* / Q000473:pathology; D017154:Stromal Cells / Q000166:cytology / Q000378:metabolism; D059016:Tumor Microenvironment / Q000502:physiology*
D045726:Metalloproteases
Nature. 2001 May 17;411(6835):375-9
11357145
Nat Rev Cancer. 2004 Nov;4(11):839-49
15516957
Annu Rev Cell Biol. 1993;9:541-73
8280471
Lancet. 1988 Jul 16;2(8603):135-7
2899190
Breast Cancer Res. 2003;5(3):130-5
12793893
J Cell Physiol. 2002 Sep;192(3):259-67
12124771
Mol Imaging. 2003 Jul;2(3):159-75
14649059
J Gastroenterol Hepatol. 2003 Jun;18(6):666-72
12753148
Nature. 2002 Dec 19-26;420(6917):860-7
12490959
Math Biosci. 2002 Nov-Dec;180:307-28
12387930
Nat Med. 1997 Feb;3(2):177-82
9018236
Virchows Arch. 1997 Jun;430(6):433-43
9230908
Science. 1997 Jul 11;277(5323):225-8
9211848
Neoplasia. 2003 Mar-Apr;5(2):135-45
12659686
Cancer Res. 1996 Dec 15;56(24):5745-53
8971186
Nat Rev Cancer. 2004 Nov;4(11):891-9
15516961
Clin Exp Metastasis. 1989 May-Jun;7(3):277-82
2647331
Int J Cancer. 2003 Dec 10;107(5):688-95
14566816
Gastrointest Radiol. 1990 Summer;15(3):233-7
2160391
Biochimie. 2005 Mar-Apr;87(3-4):321-8
15781319
Gen Diagn Pathol. 1997 Feb;142(3-4):155-63
9065579
Trends Cell Biol. 2001 Nov;11(11):S37-43
11684441
Cancer. 1992 Jul 1;70(1):45-9
1318778
J Nucl Med. 2008 Jun;49 Suppl 2:24S-42S
18523064
Cell. 1997 Nov 14;91(4):439-42
9390552
Cancer Res. 1989 Aug 15;49(16):4373-84
2545340
Cancer Res. 2006 May 15;66(10):5216-23
16707446
Eur J Cancer. 1999 Aug;35(8):1274-80
10615241
Breast Cancer Res Treat. 1997 Apr;43(2):175-81
9131273
Nat Rev Cancer. 2001 Oct;1(1):46-54
11900251
Math Biosci. 2009 Jul;220(1):45-56
19376138
J Pathol. 2003 Jul;200(4):429-47
12845611
Cancer. 2006 Apr 15;106(8):1669-76
16534796
Int J Biochem Cell Biol. 2007;39(7-8):1358-66
17499003
Semin Cancer Biol. 2000 Dec;10(6):415-33
11170864
Clin Exp Metastasis. 1999 Jul;17(5):397-407
10651306
Cancer Res. 2003 Jul 15;63(14):3847-54
12873971